Dr. Jan Schmidt-Brand has been Chief Executive Officer of Heidelberg Pharma AG since 2014 and Chief Financial Officer since 2012.
Until the acquisition by WILEX AG (former name of the Company), Dr. Schmidt-Brand held the position of CEO/CFO in the former Heidelberg Pharma GmbH.
He has over 25 years’ experience in leading positions in the commercial as well as the fiscal sector of pharmaceutical companies.
From 1997 to 2001 he was Managing Director of EBEWE Arzneimittel GmbH, an Austrian BASF Pharma subsidiary.
Prior to this, he held several positions at the BASF Group for a total of eight years, most recently as an executive in the central tax department.
Dr. Schmidt-Brand studied law, business management and French at the universities of Bayreuth and Geneva and obtained his doctoral degree from the University of Mannheim.